Angiotensin receptor-neprilysin inhibition in patients with de novo acute decompensated heart failure: a prespecified subgroup analysis of the PIONEER-HF trial
Publication
, Conference
Ambrosy, A; Braunwald, E; Morrow, D; Devore, A; McCague, K; Duffy, C; Rocha, R; Velazquez, E
Published in: EUROPEAN HEART JOURNAL
October 1, 2019
Duke Scholars
Published In
EUROPEAN HEART JOURNAL
EISSN
1522-9645
ISSN
0195-668X
Publication Date
October 1, 2019
Volume
40
Start / End Page
638 / 638
Location
Paris, FRANCE
Publisher
OXFORD UNIV PRESS
Conference Name
Congress of the European-Society-of-Cardiology (ESC) / World Congress of Cardiology
Related Subject Headings
- Cardiovascular System & Hematology
- 3202 Clinical sciences
- 3201 Cardiovascular medicine and haematology
- 1103 Clinical Sciences
- 1102 Cardiorespiratory Medicine and Haematology
Citation
APA
Chicago
ICMJE
MLA
NLM
Ambrosy, A., Braunwald, E., Morrow, D., Devore, A., McCague, K., Duffy, C., … Velazquez, E. (2019). Angiotensin receptor-neprilysin inhibition in patients with de novo acute decompensated heart failure: a prespecified subgroup analysis of the PIONEER-HF trial. In EUROPEAN HEART JOURNAL (Vol. 40, pp. 638–638). Paris, FRANCE: OXFORD UNIV PRESS.
Ambrosy, A., E. Braunwald, D. Morrow, A. Devore, K. McCague, C. Duffy, R. Rocha, and E. Velazquez. “Angiotensin receptor-neprilysin inhibition in patients with de novo acute decompensated heart failure: a prespecified subgroup analysis of the PIONEER-HF trial.” In EUROPEAN HEART JOURNAL, 40:638–638. OXFORD UNIV PRESS, 2019.
Ambrosy A, Braunwald E, Morrow D, Devore A, McCague K, Duffy C, et al. Angiotensin receptor-neprilysin inhibition in patients with de novo acute decompensated heart failure: a prespecified subgroup analysis of the PIONEER-HF trial. In: EUROPEAN HEART JOURNAL. OXFORD UNIV PRESS; 2019. p. 638–638.
Ambrosy, A., et al. “Angiotensin receptor-neprilysin inhibition in patients with de novo acute decompensated heart failure: a prespecified subgroup analysis of the PIONEER-HF trial.” EUROPEAN HEART JOURNAL, vol. 40, OXFORD UNIV PRESS, 2019, pp. 638–638.
Ambrosy A, Braunwald E, Morrow D, Devore A, McCague K, Duffy C, Rocha R, Velazquez E. Angiotensin receptor-neprilysin inhibition in patients with de novo acute decompensated heart failure: a prespecified subgroup analysis of the PIONEER-HF trial. EUROPEAN HEART JOURNAL. OXFORD UNIV PRESS; 2019. p. 638–638.
Published In
EUROPEAN HEART JOURNAL
EISSN
1522-9645
ISSN
0195-668X
Publication Date
October 1, 2019
Volume
40
Start / End Page
638 / 638
Location
Paris, FRANCE
Publisher
OXFORD UNIV PRESS
Conference Name
Congress of the European-Society-of-Cardiology (ESC) / World Congress of Cardiology
Related Subject Headings
- Cardiovascular System & Hematology
- 3202 Clinical sciences
- 3201 Cardiovascular medicine and haematology
- 1103 Clinical Sciences
- 1102 Cardiorespiratory Medicine and Haematology